CAS 100021-05-4

Levonorgestrel EP Impurity P

CAS : 100021-05-4

Formule : C₂₁H₂₈O₂

Masse moléculaire : 312.45

Ref: ST-EA-CP-L19016

Levonorgestrel EP Impurity P

CAS : 100021-05-4

Formule : C₂₁H₂₈O₂

Couleur et forme : White To Off-White Solid

Masse moléculaire : 312.45

Ref: 4Z-L-2210

5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (>90%)

Produit contrôlé

CAS : 100021-05-4

Impurity Levonorgestrel EP Impurity P
Applications 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (Levonorgestrel EP Impurity P) is a Norgestrel (N689500) impurity.

Formule : C₂₁H₂₈O₂

Degré de pureté : >90%

Couleur et forme : Neat

Masse moléculaire : 312.45

Ref: TR-D229935

Levonorgestrel EP Impurity P

CAS : 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Degré de pureté : 90% min

Couleur et forme : Off White or Beige Solid

Masse moléculaire : 312.45

Ref: ML-LNG16

Vitamin A EP Impurity C

CAS : 100021-05-4

Soluble in Chloroform & in Methanol Confirmed
Insoluble in Wate

Degré de pureté : 90% min

Couleur et forme : Off White or Beige Solid

Masse moléculaire : 312.45

Ref: ML-VTA03

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one

Produit contrôlé

CAS : 100021-05-4

(17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one is a progestin that acts as an inhibitor of the P450 enzyme. It has been used in the treatment of women with fertility problems. (17a)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en--20--yn--3--one has shown inhibitory effects on voltage dependent calcium channels and thus may have contraceptive properties. It has also been shown to be effective in the long term treatment of intrauterine devices. Low bioavailability is a disadvantage of this drug.br>br>

Formule : C₂₁H₂₈O₂

Degré de pureté : Min. 95%

Couleur et forme : Powder

Masse moléculaire : 312.45 g/mol

Ref: 3D-FE20961